Eric Pauwels, CHIEF BUSINESS OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 22,140 shares at $57.67 ($1.2M) on 2025-03-17, disclosed to the SEC on 2025-03-18.
Scheduled sale ($1.2M) by CHIEF BUSINESS OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.19 | 4,458 | $246K | 19.8% |
| 2 | $55.19 | 4,458 | $246K | 19.8% |
| 3 | $55.24 | 2,037 | $113K | 9.1% |
| 4 | $55.24 | 2,037 | $113K | 9.1% |
| 5 | $56.62 | 1,085 | $61K | 4.9% |
| 6 | $56.62 | 1,085 |
| $61K |
| 4.9% |
| 7 | $57.67 | 3,340 | $193K | 15.5% |
| 8 | $57.67 | 3,340 | $193K | 15.5% |
| 9 | $58.31 | 300 | $17K | 1.4% |
| Total | $56.13 avg | 22,140 | $1.2M | 100% |
| Filing → |
| PTCT | SELL | 2026-01-12 | $566K | — | Filing → |
| PTCT | SELL | 2026-01-08 | $242K | — | Filing → |
| PTCT | SELL | 2025-12-23 | $3.0M | — | Filing → |